Nanopartículas como antivirales: ¿un paso más en la lucha contra los virus?

Referencias bibliográficas

• L. Chen and J. Liang, “An overview of functional nanoparticles as novel emerging antiviral therapeutic agents,” Materials Science and Engineering C, vol. 112, p. 110924, Jul. 2020, doi:10.1016/j.msec.2020.110924
• M. Oswald, S. Geissler, A. Goepferich, “Targeting the Central Nervous System (CNS): A Review of Rabies Virus-Targeting Strategies,” Molecular Pharmaceutics, vol. 14, no. 7, pp. 2177–2196, Jul. 2017, doi: 10.1021/acs.molpharmaceut.7b00158
• R. W. Doms, “Basic Concepts: A Step-by-Step Guide to Viral Infection,” Viral Pathogenesis, pp. 29-40, 2016.
• V. G. Chinchar, “Replication of viruses,” Encyclopedia of Virology, A. Granoff and R. G. Webster, eds., Academic Press New York, pp. 1471-1478, 1999.
• X. Michalet, F. Pinaud, L. Bentolila, J. Tsay, S. Doose, J. Li, G. Sundaresan, A. Wu, S. Gambhir, S. Weiss, “Quantum dots for live cells, in vivo imaging, and diagnostics,” Science, vol. 307, no. 5709. Science, pp. 538–544, Jan. 2005, doi: 10.1126/science.1104274
• T. Du, K. Cai, H. Han, L. Fang, J. Liang, S. Xiao, “Probing the interactions of CdTe quantum dots with pseudorabies virus,” Scientific Reports, vol. 5, no. 1, pp. 1–10, Nov. 2015, doi: 10.1038/srep16403
• T. Du, J. Liang, N. Dong, J. Lu, Y. Fu, L. Fang, S. Xiao, H. Han, “Glutathione-Capped Ag2S Nanoclusters Inhibit Coronavirus Proliferation through Blockage of Viral RNA Synthesis and Budding,” ACS Applied Materials & Interfaces, vol. 10, no. 5, pp. 4369–4378, Feb. 2018, doi: 10.1021/acsami.7b13811
• S. Huang, J. Gu, J. Ye, B. Fang, S. Wan, C. Wang, U. Ashraf, Q. Li, X. Wang, L. Shao, Y. Song, X. Zheng, F. Cao, S. Cao, “Benzoxazine monomer derived carbon dots as a broad-spectrum agent to block viral infectivity,” Journal of Colloid and Interface Science, vol. 542, pp. 198–206, Apr. 2019, doi: 10.1016/j.jcis.2019.02.010
• D. Ting, N. Dong, L. Fang, J. Lu, J. Bi, S. Xiao, H. Han, “Multisite inhibitors for enteric coronavirus: antiviral cationic carbon dots based on curcumin,” ACS Applied Nano Materials, vol. 1, no. 10, pp. 5451–5459, Oct. 2018, doi: 10.1021/acsanm.8b00779
• Z. Lin, Y. Li, M. Guo, T. Xu, C. Wang, M. Zhao, H. Wang, T. Chen, B. Zhu, “The inhibition of H1N1 influenza virus-induced apoptosis by silver nanoparticles functionalized with zanamivir,” RSC Advances, vol. 7, no. 2, pp. 742–750, Jan. 2017, doi: 10.1039/c6ra25010f
• A. Halder, S. Das, D. Ojha, D. Chattopadhyay, A. Mukherjee, “Highly monodispersed gold nanoparticles synthesis and inhibition of herpes simplex virus infections,” Materials Science and Engineering: C, vol. 89, pp. 413–421, Aug. 2018, doi: 10.1016/j.msec.2018.04.005
• M. Lee, J. Yang, H. Jung, S. Beack, J. Choi, W. Hur, H. Koo, K. Kim, S. Yoon, S. Hahn, “Hyaluronic acid-gold nanoparticle/interferon α complex for targeted treatment of hepatitis C virus infection,” ACS Nano, vol. 6, no. 11, pp. 9522–9531, Nov. 2012, doi: 10.1021/nn302538y
• K. Ghosal, K. Sarkar, “Biomedical Applications of Graphene Nanomaterials and beyond,” ACS Biomaterials Science and Engineering, vol. 4, no. 8, pp. 2653–2703, Aug. 2018,
• Z. Song, X. Wang, G. Zhu, Q. Nian, H. Zhou, D. Yang, C. Qin, R. Tang, “Virus Capture and Destruction by Label-Free Graphene Oxide for Detection and Disinfection Applications,” Small, vol. 11, no. 9–10, pp. 1171–1176, Mar. 2015, doi: 10.1002/smll.201401706.
• F. Schandock, C. Riber, A. Röcker, J. Müller, M. Harms, P. Gajda, K. Zuwala, A. Andersen, K. Løvschall, M. Tolstrup, F. Kreppel, J. Münch, A. Zelikin, “Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses,” Adv.anced Healthcare Material, vol. 6, no. 23, p. 1700748, Dec. 2017. doi: 10.1002/adhm.201700748
• A. Vaillant, “Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection,” Antiviral Research, vol. 133, pp. 32–40, 01-Sep-2016, doi:10.1016/j.antiviral.2016.07.004
• M. Blanchet, V. Sinnathamby, A. Vaillant, P. Labonté, “Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells,” Antiviral Res., vol. 164, pp. 97–105, Apr. 2019, doi: 10.1016/j.antiviral.2019.02.009
• A. Smith, M. Kryger, B. Wohl, P. Ruiz-Sanchis, K. Zuwala, M. Tolstrup, A. Zelikin, “Macromolecular (pro)drugs in antiviral research,” Polymer Chemistry, vol. 5, no. 22. Royal Society of Chemistry, pp. 6407–6425, Nov. 2014, doi: 10.1039/c4py00624k [19] B. K. Nanjwade, H. M. Bechra, G. K. Derkar, F. V. Manvi, and V. K. Nanjwade, “Dendrimers: Emerging polymers for drug-delivery systems,” European Journal of Pharmaceutical Sciences, vol. 38, no. 3, pp. 185–196, 08-Oct-2009, doi:10.1016/j.ejps.2009.07.008B
• B. Martínez-Gualda, L. Sun, O. Martí-Marí, C. Mirabelli, L. Delang, J. Neyts, D. Schols, M. Camarasa, A. San-Félix, “Modifications in the branched arms of a class of dual inhibitors of HIV and EV71 replication expand their antiviral spectrum,” Antiviral Res., vol. 168, pp. 210–214, Aug. 2019, doi: 10.1016/j.antiviral.2019.06.006
• S. A. Khan, S. Shahid, B. Shahid, U. Fatima, S. A. Abbasi, “Green Synthesis of MnO Nanoparticles Using Abutilon indicum Leaf Extract for Biological, Photocatalytic, and Adsorption Activities,” Biomolecules, vol. 10, no. 5, p. 785, May 2020, doi:10.3390/biom10050785
• S. Choudhary, R. Kumar, U. Dalal, S. Tomar, S. N. Reddy, “Green synthesis of nanometal impregnated biomass – antiviral potential,” Materials Science Engineering: C, vol. 112, p. 110934, Jul. 2020, doi:10.1016/j.msec.2020.110934
• V. Palmieri and M. Papi, “Can graphene take part in the fight against COVID-19?,” Nano today, 100883, May. 2020, doi: 10.1016/j.nantod.2020.100883
• W. Chan, “Nano Research for COVID-19”, ACS nano, vol. 14, no. 4, pp. 3719-3720, Mar. 2020, doi: 10.1021/acsnano.0c02540